SELLAS Life Sciences Group, Inc. (SLS)

5.53 +0.25 (+4.73%) USD  |  NASDAQ  |  Mar 06, 16:00
5.52 -0.01 (-0.18%) After-Hours: 20:00
More

SELLAS Life Sciences Group Net Debt Issuance (3 Year Growth)

Net Debt Issuance (3 Year Growth) Chart

View Net Debt Issuance (3 Year Growth) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Debt Issuance (3 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Debt Issuance (3 Year Growth) Range, Past 5 Years

View Net Debt Issuance (3 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Debt Issuance (3 Year Growth) Benchmarks

View Net Debt Issuance (3 Year Growth) Benchmarks
Start Trial
Amicus Therapeutics, Inc. --
Vanda Pharmaceuticals, Inc. --
GT Biopharma, Inc. --
ADMA Biologics, Inc. --
Lyell Immunopharma, Inc. --